Bio-Works
Bio-Works Technologies AB is a Swedish public manufacturer of next-generation agarose-based chromatography resins and pre-packed columns (WorkBeads, GoBio, BabyBio) for biopharmaceutical purification, serving biotech and biopharma customers from research through GMP manufacturing globally.
- Company typePublic
- Founded2006
- HeadquartersUppsala, Sweden
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Bio-Works does
Bio-Works Technologies AB is a Swedish public company, founded in 2006 and headquartered in Uppsala, that designs, manufactures, and supplies agarose-based chromatography resins used in the purification of biopharmaceutical products. The company's core product platform is WorkBeads — porous agarose beads with a patented cross-linking process that delivers tight bead- and pore-size distribution — sold across affinity (including the WorkBeads affimAb Edge Protein A resin), ion exchange (IEX), immobilized metal affinity (IMAC), hydrophobic interaction (HIC), and size exclusion (SEC) chromatography modalities. The portfolio is completed by GoBio pre-packed process columns, BabyBio small-scale screening columns, and OptioBio development columns, covering the full workflow from research screening to GMP manufacturing. ISO 9001:2015 certified, with all R&D, production, and sales operations consolidated at a single Uppsala Fyrislund site.
Revenue is generated primarily through direct sales of bulk WorkBeads resin and GoBio pre-packed columns to biopharmaceutical and biotech customers, supplemented by a global distributor network that now includes Zenmindes Biotechnology for the Chinese market (partnership signed autumn 2025). Reported full-year 2025 net sales were SEK 62.5M, up from SEK 25.5M in 2024, with gross margins of 77% and 99% on-time delivery in 2024. Disclosed customers include Abera Bioscience, Nemysis, MDX, Miltenyi, and academic groups such as Jagiellonian University, alongside a returning European biopharma customer that placed a SEK 8.3M order for 69L of WorkBeads affimAb. Sales cycles are characteristically long at 3-5 years from initial development engagement through GMP commercial supply, and 15+ commercial drugs are reported to be purified using WorkBeads resins.
The company is led by CEO Lone Carlbom, is listed on the Spotlight Stock Market (also tradable on Frankfurt as fra:1BD), and operates with a small organizational footprint anchored in Uppsala. As of year-end 2025, Bio-Works held SEK 34.9M in cash, with management claiming full funding through to break-even (targeted for 2027), supported by capital raised via the TO 2 warrant series issued in August 2024 at SEK 1/share and subsequently exercised in tranches through early 2026.
Bio-Works firmographics
Firmographics- Name
- Bio-Works
- Legal name
- Bio-Works Technologies AB
- Website
- https://bio-works.com
- Company type
- Public
- Founded year
- 2006
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Bio-Works Technologies AB is a Swedish public manufacturer of next-generation agarose-based chromatography resins and pre-packed columns (WorkBeads, GoBio, BabyBio) for biopharmaceutical purification, serving biotech and biopharma customers from research through GMP manufacturing globally.
- Ownership category
- akta.pro rank
Bio-Works industry classification
Industry- Product category
- Bioprocessing Chromatography Resins
- NAICS
- Analytical Laboratory Instrument Manufacturing (334516), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Bioprocess Development & Scale-Up/Scale-Down Platforms (DoE, high-throughput, modeling) (HLAAAJAF)
Keywords
Where Bio-Works is headquartered
LocationHeadquarters
- HQ city
- Uppsala
- HQ country
- Sweden
- HQ region
- Europe
Offices1 record
Markets served
Bio-Works business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales
Revenue model
- Chromatography Resins and Pre-packed Columns: Bio-Works generates revenue through the sale of chromatography resins (WorkBeads) and pre-packed columns (GoBio) for biomolecule purification. Products are sold directly and through distributors to biotech and biopharma customers globally. The company serves research-scale to industrial-scale production needs.
- Warrants Exercise (TO 2): Bio-Works raised SEK 17.85 million from warrant exercises in period 4 (October 2025), and SEK 1,199,471 from period 5 (January 2026). Each warrant exercises at SEK 1 per share. The company had approximately 17.5 million warrants still outstanding as of April 2026.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels6 records
Bio-Works product offering
Product offeringCore offering
Bio-Works designs, develops, manufactures and supplies next-generation agarose-based chromatography resins (WorkBeads) and pre-packed columns (GoBio, BabyBio, OptioBio) for the purification of biopharmaceuticals including monoclonal antibodies, proteins, peptides, oligonucleotides, viruses, and vaccines. The company serves customers from research scale through industrial GMP manufacturing, with a patented proprietary manufacturing process that produces porous beads with tight size and pore distribution.
Product overview
Bio-Works is a global manufacturer of next-generation agarose-based chromatography resins and pre-packed columns for purification of biopharmaceuticals. The product portfolio centers on WorkBeads™ chromatography resins (including affinity, IEX, IMAC, HIC, SEC, and activated resins), complemented by GoBio™ and BabyBio™ pre-packed column lines. The company offers standard resin formats as well as custom resin solutions, serving customers from research scale to industrial GMP manufacturing. The WorkBeads affimAb Edge represents their latest-generation Protein A resin for antibody purification.
Differentiator
Problem solved
Functional benefit
Brands
- WorkBeads: Chromatography resins for purification of biomolecules including monoclonal antibodies, proteins, peptides, oligos, viruses and vaccines. Includes WorkBeads affimAb (Protein A affinity resin), WorkBeads 40Q/100Q (AIEX resins), WorkBeads 40S/100S (CIEX resins), WorkBeads NiMAC (IMAC), WorkBeads SEC (size exclusion), and WorkBeads 40 TREN (multimodal IEX).
- GoBio
- BabyBio
- OptioBio
Products and services
- WorkBeads Affinity Chromatography Resins
Quantifiable outcome
- Production capacity increased approximately 80% during 2025
- +6 more outcomes
Companies that use Bio-Works
Customer profileNamed customers6 records
Segments4 records
Ideal customer profiles4 records
Bio-Works technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Bio-Works partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Zenmindes Biotechnology Co., Ltd.coreStrategic partnership signed in autumn 2025 to establish a strong and sustainable presence in China's rapidly expanding biopharmaceutical market. Zenmindes has deep understanding of the complex purification needs of local markets and helps get Bio-Works involved earlier in customers' development phases, accelerating the typically long 3-5 year sales cycle in biopharma.
Scale indicators13 records
Recent moves5 records
Expansion highlights4 records
Bio-Works competitors and assessment
Company assessmentDirect peers
- Cytiva: Cytiva (formerly GE Healthcare Life Sciences) is the global market leader in chromatography resins for bioprocessing, with flagship Protein A resins (MabSelect) and a full IEX/IMAC/SEC/HIC portfolio. Cytiva is the most direct competitor to Bio-Works in WorkBeads' target applications, particularly mAb purification and commercial-scale biomanufacturing.
- Tosoh Bioscience: Tosoh Bioscience manufactures Toyopearl and TSKgel chromatography resins widely used in biopharmaceutical purification, including IEX, HIC, SEC, and affinity modes. Tosoh is a direct competitor to Bio-Works in process-scale resin supply, particularly in Asia where both companies compete for biopharma purification share.
- Bio-Rad Laboratories: Bio-Rad manufactures chromatography resins including UNOsphere, Nuvia, and Macro-Prep product lines for protein and biomolecule purification. Bio-Rad's process chromatography business directly overlaps with Bio-Works' WorkBeads portfolio across IEX, affinity, and SEC modes for research-to-process scale applications.
- Repligen Corporation: Repligen is a pure-play bioprocessing specialist whose AVIPure Protein A resins and OPUS pre-packed columns compete directly with WorkBeads affimAb and GoBio in mAb and bispecific antibody purification. Repligen's focus on chromatography and bioprocess solutions makes it a particularly close comparable for Bio-Works' commercial strategy.
- Purolite (an Ecolab company): Purolite launched the Praesto range of agarose-based chromatography resins in 2018 specifically targeting bioprocessing. As a relatively newer direct entrant into bioprocess chromatography with comparable agarose bead technology, Purolite is one of the closest direct competitors to Bio-Works' WorkBeads in mAb and protein purification.
Broad incumbents
- Merck KGaA (Life Science / MilliporeSigma): Merck's Life Science sector (MilliporeSigma) supplies Eshmuno and ProSep chromatography resins alongside a much broader bioprocessing and lab products portfolio. As a broad incumbent with deep customer relationships across biopharma, Merck competes with Bio-Works in chromatography resins while also offering end-to-end process solutions that Bio-Works does not.
- Sartorius AG: Sartorius is a major bioprocess equipment and consumables supplier whose Sartobind and CIMmultus membrane chromatography products compete in biomolecule purification. Sartorius' broad bioprocessing portfolio (upstream + downstream + fill-finish) and large installed base in commercial biomanufacturing make it a broad incumbent competitor to Bio-Works in process chromatography.
- Thermo Fisher Scientific: Thermo Fisher's bioproduction and chromatography offering includes POROS resins, CaptureSelect affinity ligands, and a broad life sciences portfolio. While Bio-Works competes specifically against the chromatography product lines, Thermo Fisher's global scale and bundling across instruments, consumables, and services create significant competitive pressure in commercial-scale accounts.
- Avantor: Avantor distributes and supplies chromatography resins and bioprocessing consumables globally to biopharma manufacturers, including J.T.Baker and own-brand chromatography products. Avantor's broad product distribution and global scale make it a relevant incumbent competitor in the same end-customer accounts that Bio-Works targets.
- Agilent Technologies: Agilent Technologies supplies chromatography products including Bio-Monolith and CrossLab bioprocess solutions, alongside a broader analytical instruments and life sciences portfolio. Agilent is a relevant broad incumbent with overlapping chromatography capability, particularly in analytical and small-scale purification adjacencies to Bio-Works' process-scale resins.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Bio-Works social profiles
Digital presenceBio-Works compliance and trust
Trust signalCompliance1 record
Bio-Works financial estimates
Financial estimateRevenue estimate
Valuation estimate
Bio-Works leadership team
Management profileNumber of profiles
Profiles2 records
Bio-Works funding detail
Funding detailFunding overview
Funding rounds6 records
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Bio-Works M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Bio-Works
What does Bio-Works do?
Bio-Works designs, develops, manufactures and supplies next-generation agarose-based chromatography resins (WorkBeads) and pre-packed columns (GoBio, BabyBio, OptioBio) for the purification of biopharmaceuticals including monoclonal antibodies, proteins, peptides, oligonucleotides, viruses, and vaccines. The company serves customers from research scale through industrial GMP manufacturing, with a patented proprietary manufacturing process that produces porous beads with tight size and pore distribution.
Is Bio-Works a public or private company?
Bio-Works is a public company. It is classified as public and is currently operating.
When was Bio-Works founded?
Bio-Works was founded in 2006. It employs 11 to 50 people.
Where is Bio-Works based?
Bio-Works is headquartered in Uppsala, Sweden, in the Europe region.
How does Bio-Works make money?
Two revenue lines are on record. Chromatography Resins and Pre-packed Columns are the primary driver. The others are warrants Exercise (TO 2).
Who are Bio-Works's main competitors?
Direct peers on record are Cytiva, Tosoh Bioscience, Bio-Rad Laboratories, Repligen Corporation and Purolite (an Ecolab company). Broad incumbents are Merck KGaA (Life Science / MilliporeSigma), Sartorius AG, Thermo Fisher Scientific, Avantor and Agilent Technologies.
Does Bio-Works have an API?
No public API is recorded for Bio-Works.
What industry is Bio-Works in?
Bio-Works's product category is Bioprocessing Chromatography Resins. Its primary akta.pro industry code is HLAAAJAF, Bioprocess Development & Scale-Up/Scale-Down Platforms (DoE, high-throughput, modeling). Its NAICS code is 334516 and its SIC code is 2833.